GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $28,000 | 0.0% | 636 | 0.0% | 0.01% | +16.7% |
| Q1 2022 | $28,000 | 0.0% | 636 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $28,000 | +16.7% | 636 | 0.0% | 0.01% | +20.0% |
| Q3 2021 | $24,000 | -4.0% | 636 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $25,000 | +8.7% | 636 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $23,000 | 0.0% | 636 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $23,000 | -4.2% | 636 | 0.0% | 0.01% | -14.3% |
| Q3 2020 | $24,000 | -7.7% | 636 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $26,000 | +8.3% | 636 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $24,000 | -20.0% | 636 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $30,000 | +11.1% | 636 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $27,000 | +8.0% | 636 | 0.0% | 0.01% | +14.3% |
| Q2 2019 | $25,000 | -7.4% | 636 | 0.0% | 0.01% | -12.5% |
| Q1 2019 | $27,000 | +12.5% | 636 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $24,000 | -7.7% | 636 | 0.0% | 0.01% | -11.1% |
| Q3 2018 | $26,000 | 0.0% | 636 | 0.0% | 0.01% | -10.0% |
| Q2 2018 | $26,000 | +4.0% | 636 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $25,000 | +8.7% | 636 | 0.0% | 0.01% | +11.1% |
| Q4 2017 | $23,000 | -11.5% | 636 | 0.0% | 0.01% | -18.2% |
| Q3 2017 | $26,000 | -3.7% | 636 | 0.0% | 0.01% | -8.3% |
| Q2 2017 | $27,000 | 0.0% | 636 | 0.0% | 0.01% | -7.7% |
| Q1 2017 | $27,000 | +12.5% | 636 | 0.0% | 0.01% | +8.3% |
| Q4 2016 | $24,000 | -11.1% | 636 | 0.0% | 0.01% | -14.3% |
| Q3 2016 | $27,000 | -3.6% | 636 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $28,000 | +7.7% | 636 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $26,000 | 0.0% | 636 | 0.0% | 0.01% | -6.7% |
| Q4 2015 | $26,000 | +8.3% | 636 | 0.0% | 0.02% | +7.1% |
| Q3 2015 | $24,000 | -7.7% | 636 | 0.0% | 0.01% | -6.7% |
| Q2 2015 | $26,000 | -10.3% | 636 | 0.0% | 0.02% | -11.8% |
| Q1 2015 | $29,000 | +7.4% | 636 | 0.0% | 0.02% | 0.0% |
| Q4 2014 | $27,000 | -60.3% | 636 | -50.0% | 0.02% | -63.8% |
| Q4 2013 | $68,000 | – | 1,272 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |